The age factor in Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease is the most common type of dementia, and it is characterized by a decline in memory or other thinking skills.The greatest risk factor for Alzheimer's disease is advanced age.A recent genome-wide study identified a locus on chromosome 17 associated with the age at onset, and a specific variant in CCL11 is probably responsible for the association.The association of a protective haplotype with a 10-year delay in the onset of Alzheimer's disease and the identification of a CCL11 variant with possible functional roles in this association might allow the future development of immunomodulators with the potential to halve disease incidence.Alzheimer's disease (AD) is a common and multifactorial neurodegenerative disease.It is one of the leading causes of death around the world and is associated with substantial direct and indirect costs for families and societies.The vast majority of AD cases have a late onset (usually after 65 years of age); the disease is rare among younger individuals.Incidence of AD is known to increase with age, and age is the most important risk factor for the development of AD.The ability to delay the age at onset (AAO) of this disease through preventive or therapeutic approaches would have significant benefits, but no therapies have been successful in achieving this important goal [1,2].A recent study by Lalli et al.[3] used genome-wide technologies to identify genetic modifiers of AAO in a unique cohort comprising an extended Colombian family carrying the PSEN1 p.E280A mutation, and the outcome might be useful for guiding the search for therapies.Age at onset as a highly heritable factor in AD AAO is highly heritable in AD families.In early-onset cases, mutations in three genes are known to account
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The baby boom generation (Americans born between 1946 and 1964) has already begun to reach age 65 and beyond, 219 the age range of greatest risk of Alzheimer's dementia; 220”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [220]
The cited source says what the claim attributes to it.
In the citing paper
“Ageing is the greatest risk factor for AD [26, 53, 60] and is associated with cellular senescence.”
From Characterisation of premature cell senescence in Alzheimer's disease using single nuclear transcriptomics (2024) · cites this paper as [26]
The cited source says what the claim attributes to it.
In the citing paper
“while ageing increases the incidence of the progressive neurodegenerative disease [59].”
From PCSK9 acts as a key regulator of Aβ clearance across the blood–brain barrier (2022) · cites this paper as [59]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A growing number of studies indicate that the prevalence 220,239,264,[318][319][320][321][322][335][336][337] and incidence 268,[335][336][337][338][339][340][341][342][343][344] of Alzheimer's and other dementias in the United States and other high-income countries may have declined in the past 25 years, 268,276,[335][336][337][338][339][340][341][342][343][345][346][347][348] though results are”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [220]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Brookmeyer, R., Gray, S., & Kawas, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,787
The ageing systemic milieu negatively regulates neurogenesis and cognitive function
Villeda, S. A., Luo, J., Mosher, K. I., Zou, B., Britschgi, M., Bieri, G., Stan, T. M., Fainberg, N., Ding, Z., Eggel, A., et al. (2011) · Nature · doi:10.1038/nature10357 · Cited by 1,763
A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
Jonsson, T., Atwal, J. K., Steinberg, S., Snaedal, J., Jonsson, P. V., Bjornsson, S., Stefansson, H., Sulem, P., Gudbjartsson, D., Maloney, J., et al. (2012) · Nature · doi:10.1038/nature11283 · Cited by 1,738
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657 · cited 1×
“nificant for AD and TYROBP as the driver gene for this module [7, 8].”
Background2015 Alzheimer's disease facts and figures
Alzheimer's Association (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.02.003 · Cited by 1,635
Lombardo, I., Ramaswamy, G., Piscitelli, S. C., & Friedhoff, L. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.08.154 · Cited by 656
Convergent genetic and expression data implicate immunity in Alzheimer's disease
International Genomics of Alzheimer's Disease Consortium (IGAP), Jones, L., Lambert, J., Wang, L., Choi, S., Harold, D., Vedernikov, A., Escott‐Price, V., Stone, T., Richards, A., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.05.1757 · Cited by 199
Naj, A. C., Jun, G., Reitz, C., Kunkle, B. W., Perry, W., Park, Y. S., Beecham, G. W., Rajbhandary, R. A., Hamilton-Nelson, K. L., Wang, L.-S., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1491 · Cited by 185
Cited by
2023 Alzheimer's disease facts and figures
(2023) · Alzheimer's & Dementia · doi:10.1002/alz.13016 · Cited by 3,212
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
Breijyeh, Z., & Karaman, R. (2020) · Molecules · doi:10.3390/molecules25245789 · Cited by 2,789
2024 Alzheimer's disease facts and figures
(2024) · Alzheimer's & Dementia · doi:10.1002/alz.13809 · Cited by 2,536
2022 Alzheimer's disease facts and figures
(2022) · Alzheimer's & Dementia · doi:10.1002/alz.12638 · Cited by 2,341
2020 Alzheimer's disease facts and figures
(2020) · Alzheimer's & Dementia · doi:10.1002/alz.12068 · Cited by 2,353
Metadata
- Authors
- Guerreiro, R., & Bras, J.
- Affiliations
- UCL Queen Square Institute of Neurology (GB)
- Corresponding author
- Guerreiro, Rita
- ORCID
- Guerreiro, Rita
- Venue
- Genome Medicine
- Published
- 2015-10-20
- Volume
- 7
- Issue
- 1
- Pages
- 106-106
- ISSN
- 1756-994X (ISSN-L)
- PMC
- PMC4617238
- OpenAlex
- W1761228750
- Cited by
- 415
- References
- 13
- Citations by year
- 2026: 30 · 2025: 48 · 2024: 68 · 2023: 60 · 2022: 65 · 2021: 53 · 2020: 42 · 2019: 33 · 2018: 12 · 2017: 3 · 2016: 1
- FWCI
- 3.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Genome Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Alzheimer's Society
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- Alzheimer's disease, age of onset, late-onset Alzheimer's disease, age as risk factor, eotaxin, genetic modifiers, PSEN1 E280A mutation, heritability, protective haplotypes, immunomodulators
- MeSH terms
- Age Factors, Alzheimer Disease, Animals, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The age factor in Alzheimer’s disease. https://app.cochat.ai/papers/10.1186/s13073-015-0232-5
- The paper
- Guerreiro, R., & Bras, J. (2015). The age factor in Alzheimer’s disease. Genome Medicine. https://doi.org/10.1186/s13073-015-0232-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.